Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Conflicted on These Technology Names: Salesforce (CRM) and Leidos Holdings (LDOS)

Tipranks - Sun Apr 19, 12:08AM CDT

Analysts have been eager to weigh in on the Technology sector with new ratings on Salesforce (CRM) and Leidos Holdings (LDOS).

Claim 30% Off TipRanks

Salesforce (CRM)

BTIG analyst Allan Verkhovski maintained a Buy rating on Salesforce yesterday and set a price target of $255.00. The company’s shares closed last Friday at $182.14.

According to TipRanks.com, Verkhovski has 0 stars on 0-5 stars ranking scale with an average return of -21.4% and a 16.1% success rate. Verkhovski covers the Technology sector, focusing on stocks such as Zoom Video Communications, ZoomInfo Technologies, and Tyler Technologies. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Salesforce with a $261.45 average price target, a 41.0% upside from current levels. In a report issued on April 10, Truist Financial also reiterated a Buy rating on the stock.

See the top stocks recommended by analysts >>

Leidos Holdings (LDOS)

TD Cowen analyst Gautam Khanna assigned a Hold rating to Leidos Holdings on April 13 and set a price target of $175.00. The company’s shares closed last Friday at $155.17.

According to TipRanks.com, Khanna is a top 100 analyst with an average return of 21.4% and a 72.5% success rate. Khanna covers the Industrial Goods sector, focusing on stocks such as Voyager Technologies, Inc. Class A, L3Harris Technologies, and Carpenter Technology. ;'>

Currently, the analyst consensus on Leidos Holdings is a Moderate Buy with an average price target of $200.56, implying a 27.9% upside from current levels. In a report issued on March 31, Wells Fargo also initiated coverage with a Hold rating on the stock with a $165.00 price target.

Read More on CRM:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.